Safety and Effectiveness Clinical Evaluation of Injectable Medical Devices Viscol

Exclusion Criteria

• •In terms of population
• •1. Pregnant or nursing woman or planning a pregnancy during the study.
• •2. Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
• •3. Subject in a social or sanitary establishment.
• •4. Subject suspected to be non-compliant according to the investigator's judgment.
• •5. Subject having received a total of 6.000 euros as compensations for their participation in clinical research in the last 12 months, including their participation in the present study.
• •6. Subject enrolled in another study or whose non-enrollment period is not over.
• •7. Subject with scar(s), mole(s), hair or any other lesion on the studied zones which might interfere with the evaluation (tattoo, permanent make-up…). In terms of associated pathology
• •8. Subject suffering from a severe or progressive disease or any other pathology that may interfere with the evaluation of the study results and/or subject safety.
• •9. Subject with known history of or suffering from autoimmune disease and/or immune deficiency.
• •10. Subject suffering from active disease such as inflammation, infection, tumours, inflammatory and/or infectious cutaneous disorders (herpes, acne, rosacea, porphyria …) in the 6 months before screening visit.
• •11. Subject with a history of streptococcal disease or an active streptococcus infection.
• •12. Subject prone to develop inflammatory skin conditions or having tendency to bleeding disorders